Plain-English translation of NCT07392879 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using virtual reality to experience nature—through an advanced headset called Apple Vision Pro—can help reduce depression in people with progressive multiple sclerosis. Participants will use the VR headset at home to take immersive nature walks. The study wants to see whether this new treatment works better for depression when combined with standard depression care (like medication or therapy) compared to standard care alone.
Depression is common in people with multiple sclerosis and can be hard to treat. Researchers think that immersive experiences of nature through virtual reality might help ease depression symptoms, reduce stress and anxiety, improve sleep, and decrease fatigue—and this trial will test whether that's true.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups. Some groups will start with 8 weeks of using the VR headset at home to take nature walks, either alongside your regular depression treatment or on its own. After a 1-week break, you may switch to a different phase of the study (such as standard care alone or VR plus standard care). The study lasts approximately 17 weeks total for most participants. You'll use the VR headset at home on your own schedule, and researchers will check in with you about your depression symptoms, stress, sleep, and energy levels.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States